EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity

Liridona Useini iD, Marija Mojić iD, Markus Laube iD, Peter Lönnecke iD, Sanja Mijatović iD, Danijela Maksimović-Ivanić iD, Jens Pietzsch iD, Evamarie Hey-Hawkins iD

ChemMedChem · 2023

DOI: 10.1002/cmdc.202200583 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemMedChem, 2023. Verfasst von Liridona Useini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Chemistry and Mineralogy, Institute of Inorganic Chemistry, Leipzig University, 04103, Leipzig, Germany. Hauptthemen laut MEDLINE: Arthritis, Rheumatoid, Boranes. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Deutsche Forschungsgemeinschaft.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Fenoprofen is a widely used nonsteroidal anti‐inflammatory drug (NSAID) against rheumatoid arthritis, degenerative joint disease, ankylosing spondylitis and gout. Like other NSAIDs, fenoprofen inhibits the synthesis of prostaglandins by blocking both cyclooxygenase (COX) isoforms, COX‐1 the “house‐keeping” enzyme and COX‐2 the induced isoform from pathological stimuli. Unselective inhibition of both COX isoforms results in many side effects, but off‐target effects have also been reported. The steric modifications of the drugs could afford the desired COX‐2 selectivity. Furthermore, NSAIDs have shown promising cytotoxic properties. The structural modification of fenoprofen using bulky dicarba‐ closo ‐dodecaborane(12) (carborane) clusters and the biological evaluation of the carborane analogues for COX inhibition and antitumor potential showed that the carborane analogues exhibit stronger antitumor potential compared to their respective aryl‐based compounds.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthritis, RheumatoidBoranesHumansFenoprofenCyclooxygenase 2Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 Inhibitors

Stichwörter der Autor:innen

COX inhibitorsCarboranecancerdrug designfenoprofen

Substanzen

FenoprofenCyclooxygenase 2Anti-Inflammatory Agents, Non-SteroidalBoranesCyclooxygenase 2 Inhibitors

Autor:innen und Institutionen

  • Faculty of Chemistry and Mineralogy, Institute of Inorganic Chemistry, Leipzig University, 04103, Leipzig, Germany.
  • Institute for Biological Research "Siniša Stanković", National Institute of Republic of Serbia, University of Belgrade, 11060, Belgrade, Serbia.
  • Department of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf (HZDR), 01328, Dresden, Germany.
  • Faculty of Chemistry and Food Chemistry, School of Science, Technische Universität Dresden, 01069, Dresden, Germany.

ORCID-Profile: Liridona Useini, Marija Mojić, Markus Laube, Peter Lönnecke, Sanja Mijatović, Danijela Maksimović-Ivanić, Jens Pietzsch, Evamarie Hey-Hawkins

Förderung

  • Deutsche Forschungsgemeinschaft

Zitieren

APA

Useini, L., Mojić, M., Laube, M., Lönnecke, P., Mijatović, S., Maksimović-Ivanić, D., Pietzsch, J., & Hey-Hawkins, E. (2023). Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity. ChemMedChem. https://doi.org/10.1002/cmdc.202200583

Vancouver

Useini L, Mojić M, Laube M, Lönnecke P, Mijatović S, Maksimović-Ivanić D, et al. Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity. ChemMedChem. 2023. doi:10.1002/cmdc.202200583

BibTeX
@article{Useini2023,
  author = {Useini, Liridona and Mojić, Marija and Laube, Markus and Lönnecke, Peter and Mijatović, Sanja and Maksimović-Ivanić, Danijela and Pietzsch, Jens and Hey-Hawkins, Evamarie},
  title = {Carborane Analogues of Fenoprofen Exhibit Improved Antitumor Activity},
  journal = {ChemMedChem},
  year = {2023},
  doi = {10.1002/cmdc.202200583}
}
Kostenlos starten →